← Open Payments lookup

MARLA LEHMANN: Open Payments

NPI 1487824710 · CARROLLTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,160 in 54 payments from 23 companies in 2025. Trend: 2023 $1,379 · 2024 $1,000 · 2025 $1,160

Food & beverage: $1,160
CompanyPaymentsAmount
Novo Nordisk Inc9$167
AstraZeneca Pharmaceuticals LP2$151
GlaxoSmithKline, LLC.7$129
Abbott Laboratories4$112
Gilead Sciences, Inc.3$76
ABBVIE INC.4$69
Boehringer Ingelheim Pharmaceuticals, Inc.3$59
Axsome Therapeutics, Inc.3$58
Lilly USA, LLC3$51
Astellas Pharma US Inc3$51

Products named: BREZTRI, Wegovy, TRELEGY ELLIPTA, FREESTYLE LIBRE 3, Auvelity, CONFIRM RX, Veozah, UBRELVY.

Industry payments across TX — which companies pay providers there.